I got whacked a bit by the market since my last update, but still decently in the black for the year.

PERI announced earnings. Let’s see….. Non-GAAP income was $.49 up from $.33 last year. Made $1.13 for the year, and have $7.65 a share in net cash–after they bought back $71 million of their own stock in 2025. They expect at least a 10% increase in EBITDA for 2026 which should translate to the same type of EPS increase. Trading at $1.35 above net cash value. Just insane.

VNDA got their second FDA approval on Friday. The stock was up 44% after hours.

ACH reported earnings. EPS was $.21 for the quarter (from continuing operations) and $1.01 for the year. They lost a low margin contract, so revenues will drop about 7% in 2026 and EBITDA will drop 5-10%. So EPS may “only” be about $.90. Trading at $2.60, 2.9X forward EPS. Yes, they have a pile of debt, but this is way CHEAP, IMO.